Omeros | OMER - Vermögenswerte





Vermögenswerte Veränderung Datum
Adma Biologics USD 624.24M 55.56M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Cytokinetics USD 1.27B 151.06M 2026-03
Gilead Sciences USD 59.02B 490M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Immunic USD 24.05M 16.65M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
Rockwell Medical USD 52.62M 1.34M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
United Therapeutics USD 6.71B 1.17B 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03
Xoma USD 263.15M 39.7M 2025-09